Get started
Author

Sara Basinski

ORCID: 0009-0001-2832-3691
Observed ORCID: 0009-0001-2832-3691
OpenAlex ID: A5093042430
PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al. · Cancer Research Communications · 13
PDF
1060 DF9001, an EGFR targeted immune engager, stimulates innate and adaptive anti-tumor immunity with a distinctive safety profile
2024 · Mitchell Bigelow, Colin LaCroix, et al. · Journal for ImmunoTherapy of Cancer · 3
Preclinical Efficacy of VTX-0811: A Humanized First-in-Class PSGL-1 mAb Targeting TAMs to Suppress Tumor Growth
2024 · Tatiana Novobrantseva, Denise Manfra, et al. · Cancers · 2
PDF
Data from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al. · 1
962 A novel alpha-active IL-2-Fc has expanded therapeutic index and robust monotherapy efficacy in mouse cancer models and strong synergy with PD-1 blockade
2024 · Adam P Stockmann, Sylvia Vincent, et al. · Journal for ImmunoTherapy of Cancer
FIGURE 1 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
Supplementary Figure 6 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
Supplementary Figure 4 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
Supplementary Table 3 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
Supplementary Figure 1 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
Supplementary Figure 2 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
Supplementary Table 1 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
FIGURE 4 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
FIGURE 5 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
Supplementary Figure 1 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
Supplementary Figure 3 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
FIGURE 5 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
FIGURE 2 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
Supplementary Table 2 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
FIGURE 3 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
Data from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
Supplementary Figure 9 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
FIGURE 1 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
Supplementary Figure 7 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
Supplementary Figure 5 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023 · Kevin Kauffman, Denise Manfra, et al.
Works count: 28
Citation count: 19
H-index: 2
I10-index: 1
Year
Topic
Type